Swedish Orphan Biovitrum AB reports Q4 results
Source: SeekingAlpha
2026-02-05 06:39:47 ET
More on Swedish Orphan Biovitrum AB (publ)
- Swedish Orphan Biovitrum AB (publ) (SWOBY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Swedish Orphan Biovitrum AB (publ) (SWOBY) M&A Call Transcript
- Swedish Orphan Biovitrum AB (publ) (SWOBY) Arthrosi Therapeutics, Inc. - M&A Call - Slideshow
- Sobi, Apellis win EU nod for Aspaveli against rare kidney diseases
- Seeking Alpha’s Quant Rating on Swedish Orphan Biovitrum AB (publ)
Read the full article on Seeking Alpha
For further details see:
Swedish Orphan Biovitrum AB reports Q4 results
Swedish Orphan Biovit Ord
NASDAQ: BIOVF
BIOVF Trading
-2.12% G/L:
$41.32 Last:
345 Volume:
$42.215 Open:
